• Login
  • Register
Nairametrics
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
No Result
View All Result
Nairametrics
No Result
View All Result
Home Business News Coronavirus
AstraZeneca suspends COVID-19 vaccine final stage trial over safety concerns, COVID-19: J&J starts vaccine trials on humans after success on monkeys

US to start large scale distribution of COVID-19 vaccine November 1

Chike OlisahbyChike Olisah
3 years ago
in Coronavirus
Share on FacebookShare on TwitterShare on Linkedin

The United States Centres for Disease Control and Prevention (CDC) has told states to get ready for a Covid-19 vaccine, which is expected to be ready by November 1, 2020, and asked them to remove obstacles that would prevent distribution sites from opening.

This disclosure is contained in a letter that was sent to the governors by the CDC Director, Dr Robert Redfield, a few days ago.

According to a report from Bloomberg, the CDC had in early August told states to assume for planning that limited doses of a vaccine could be available in fall. The new August 27 letter, which was first reported by the news organization McClatchy, sets the stage for a broader rollout. A spokesman for CDC confirmed the contents of the letter.

READ: GTBank revenue for H1, 2020 rises to N225.14 billion

The new letter said the Department of Health and Human Services and CDC were rapidly making preparations to implement large scale distribution of Covid-19 vaccines in the fall of 2020.

The date suggests that the United States government anticipates that a vaccine will become available some days before President Donald Trump stands for reelection on November 3, an aggressive goal that would depend on shots being tested and reviewed by then.

READ: CBN reviews minimum interest rates on savings deposit to 1.25%

Trump had previously said that he thought a vaccine would be ready by election day or soon before. He had also accused the staff of the Food and Drug Administration of slowing vaccine development to hurt him politically. These claims have raised questions about political interference in vaccine reviews.

While referring to the CDC letter, Health and Human Services spokesman Michael Caputo said it was increasingly likely that many vaccine doses would be available by January.

Caputo in an email said, “Doctors and data are driving the development of all Covid-19 countermeasures. FDA career scientists will make these calls, independent government experts solemnly devoted to assuring the safety and efficacy of all vaccines.”

READ: COVID-19: Amazon to identify, prosecute its third-party sellers over price-gouging

The CDC letter asks governors to hasten facility permit applications from Mckesson Corp., the distributor contracted by the government for the vaccine, and to waive rules that would prevent the sites from becoming fully operational by November 1.

Bloomberg reported this week that state health officials have separately been told to get distribution plans to the federal government by October 1.


Download Nairametrics App for breaking news and market intelligence.
   
Tags: CDCCentres for Disease Control and PreventionCOVID-19 Pandemic
Chike Olisah

Chike Olisah

Chike was a banker with over 11 years experience in retail and commercial banking, risk management, treasury portfolio management and relationship management. He also acquired some experience in financial management and do have some special interest in investment analysis and personal finance. He had stints with financial institutions like the former Intercontinental Bank and Fidelity Bank.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *







NM newsletters
Bankers committee
Kwakol
Abbey
IMT

Zenth Bank
UBA
Mega Millions

Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |

Recent News

  • FG removes VAT on Diesel for 6 months 
  • Provisional 25,000 naira increment now applies to all Federal workers – Femi Gbajabiamila
  • BUA Cement begins cement price slash to N3,500 from Oct 2nd 

Follow us on social media:

Recent News

diesel

FG removes VAT on Diesel for 6 months 

October 1, 2023
Gbajabiamila to resign as member of House of Representatives today

Provisional 25,000 naira increment now applies to all Federal workers – Femi Gbajabiamila

October 1, 2023
  • Download Nairametrics iOS App
  • Download Nairametrics Android App
  • Contact Us
  • Home
  • Exclusives
  • Markets
  • Industries
  • Economy
  • Business News
  • Financial Literacy
  • Opinions

© 2023 Nairametrics

No Result
View All Result
  • Home
  • Exclusives
    • Financial Analysis
    • Corporate Stories
    • Interviews
    • Investigations
    • Metrics
  • Markets
    • Currencies
    • Cryptos
    • Commodities
    • Equities
      • Dividends
      • Stock Market
    • Fixed Income
    • Market Views
    • Securities
  • Industries
    • Company News
    • Consumer Goods
    • Corporate Updates
    • Corporate deals
    • Corporate Press Releases
    • Energy
    • Entertainment
    • Financial Services
    • Hospitality & Travel
    • Manufacturing
    • Real Estate and Construction
    • Tech News
  • Economy
    • Nairalytics
    • Macro-Economic News
    • Research Analysis
    • Budget
    • Public Debt
  • Business News
  • Financial Literacy
    • Career tips
    • Personal Finance
  • Lifestyle
    • Billionaire Watch
    • Profiles
  • Opinions
    • Blurb
    • Op-Eds
  • Login
  • Sign Up

© 2023 Nairametrics

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In